Net profit of Vivanza Biosciences declined 44.90% to Rs 0.27 crore in the quarter ended June 2024 as against Rs 0.49 crore during the previous quarter ended June 2023. Sales declined 73.56% to Rs 2.44 crore in the quarter ended June 2024 as against Rs 9.23 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 2.44 | 9.23 | -74 |
| OPM % | 14.75 | 6.50 | - |
| PBDT | 0.27 | 0.49 | -45 |
| PBT | 0.27 | 0.49 | -45 |
| NP | 0.27 | 0.49 | -45 |